Cargando…
The Target Differences of Anti-Tumorigenesis Potential of Curcumin and its Analogues Against HER-2 Positive and Triple-Negative Breast Cancer Cells
Purpose: The current study aims to evaluate the in vitro cytotoxic and cell migration effects of synthetic curcumin and its analogues on HER2 and nuclear factor kappa B (NFκB) pathways, as well as the in vivo inhibitory effect on cancer growth of metastatic breast cancer. Methods: Cell viability, pr...
Autores principales: | Meiyanto, Edy, Husnaa, Ulfatul, Kastian, Ria Fajarwati, Putri, Herwandhani, Larasati, Yonika Arum, Khumaira, Annisa, Pamungkas, Dyaningtyas Dewi Putri, Jenie, Riris Istighfari, Kawaichi, Masashi, Lestari, Beni, Yokoyama, Takashi, Kato, Jun-ya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tabriz University of Medical Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961225/ https://www.ncbi.nlm.nih.gov/pubmed/33747866 http://dx.doi.org/10.34172/apb.2021.020 |
Ejemplares similares
-
Anti-proliferative and Anti-metastatic Potential of Curcumin Analogue, Pentagamavunon-1 (PGV-1), Toward Highly Metastatic Breast Cancer Cells in Correlation with ROS Generation
por: Meiyanto, Edy, et al.
Publicado: (2019) -
Bioinformatics and In Vitro Studies Reveal the Importance of p53, PPARG and Notch Signaling Pathway in Inhibition of Breast Cancer Stem Cells by Hesperetin
por: Hermawan, Adam, et al.
Publicado: (2021) -
Identification of potential therapeutic target of naringenin in breast cancer stem cells inhibition by bioinformatics and in vitro studies
por: Hermawan, Adam, et al.
Publicado: (2021) -
Curcumin Analog Pentagamavunon-1 (PGV-1) Sensitizes Widr Cells to 5-Fluorouracil through Inhibition of NF-κB Activation
por: Meiyanto, Edy, et al.
Publicado: (2018) -
Piperine Increases Pentagamavunon-1 Anti-cancer Activity on 4T1 Breast Cancer Through Mitotic Catastrophe Mechanism and Senescence with Sharing Targeting on Mitotic Regulatory Proteins
por: Endah, Endah, et al.
Publicado: (2022)